US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

13.39

-0.3700-2.69%

Post-market: 13.400.0100+0.07%17:48 EST

Volume:998.90K

Turnover:13.57M

Market Cap:589.49M

PE:-7.63

High:14.13

Open:13.55

Low:12.90

Close:13.76

52wk High:32.71

52wk Low:8.89

Shares:44.02M

Float Shares:23.70M

Volume Ratio:0.57

T/O Rate:4.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7539

EPS(LYR):-1.8100

ROE:-40.26%

ROA:-18.73%

PB:2.05

PE(LYR):-7.40

Loading ...

Overview Company News Filings

BRIEF-Beta Bionics Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Faruqi & Faruqi Probes Beta Bionics for Potential Investor Claims

Faruqi & Faruqi Probes Investor Claims Against Beta Bionics Inc

Beta Bionics (BBNX) Revenue Growth Outpaces Persistent Losses And Tests Bullish Narratives

Simply Wall St.

Beta Bionics Is Maintained at Neutral by Baird

Beta Bionics price target lowered to $22 from $25 at Stifel

Beta Bionics Inc : Leerink Partners Cuts Target Price to $25 From $33

THOMSON REUTERS

Hold Rating Maintained as In-Line Results and Improving Margins Offset Near-Term Prescription Headwinds

Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M

Beta Bionics reports Q4 EPS (30c), consensus (38c)

Beta Bionics Q4 sales rise 57%

BRIEF-Beta Bionics Inc Q4 EPS USD -0.3

Beta Bionics Inc. FY 2025 net loss USD 73.2 million, down 14%

Beta Bionics Inc Q4 Gross Profit USD 18.944 Million

THOMSON REUTERS

Press Release: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target

MT Newswires Live

Beta Bionics initiated with a Buy at UBS

Beta Bionics Is Maintained at Buy by Stifel

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BBNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":13.39,"timestamp":1771966800000,"preClose":13.76,"halted":0,"volume":998898,"hourTrading":{"tag":"盘后","latestPrice":13.4,"preClose":13.39,"latestTime":"17:48 EST","volume":1830,"amount":24530.74,"timestamp":1771973322393,"change":0.01,"changeRate":0.000747,"amplitude":0.005228},"delay":0,"changeRate":-0.026889534883720874,"floatShares":23702000,"shares":44024631,"eps":-1.7539035,"marketStatus":"Not Yet Opened","change":-0.37,"latestTime":"02-24 16:00:00 EST","open":13.55,"high":14.13,"low":12.9,"amount":13570063.292532,"amplitude":0.08939,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.7539035,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":13.76,"preHourTrading":{"tag":"盘前","latestPrice":13.49,"preClose":13.76,"latestTime":"09:29 EST","volume":6778,"amount":91766.43374800001,"timestamp":1771943399500,"change":-0.27,"changeRate":-0.019622,"amplitude":0.040698},"postHourTrading":{"tag":"盘后","latestPrice":13.4,"preClose":13.39,"latestTime":"17:48 EST","volume":1830,"amount":24530.74,"timestamp":1771973322393,"change":0.01,"changeRate":0.000747,"amplitude":0.005228},"volumeRatio":0.568845,"impliedVol":1.7023,"impliedVolPercentile":0.9857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":23702000,"roa":"-18.73%","roe":"-40.26%","lyrEps":-1.809999,"volumeRatio":0.568845,"shares":44024631,"dividePrice":0,"high":14.13,"amplitude":0.08939,"preClose":13.76,"low":12.9,"week52Low":8.89,"pbRate":"2.05","psRate":"5.88","week52High":32.71,"institutionHeld":0,"latestPrice":13.39,"eps":-1.7539035,"divideRate":0,"volume":998898,"delay":0,"ttmEps":-1.7539035,"open":13.55,"prevYearClose":30.47,"prevWeekClose":13.7,"prevMonthClose":13.83,"prevQuarterClose":30.47,"fiveDayClose":13.97,"twentyDayClose":15.46,"sixtyDayClose":31.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-17","symbol":"BBNX","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2026-01-08","symbol":"BBNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"BBNX","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-07-29","symbol":"BBNX","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.3636,"hold":0.2727,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1769749200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2026-02-23","current":-7.413719,"percent":0.868914,"low":-18.401318,"twenty":-15.900031,"median":-11.573987,"eighty":-8.704615,"high":-3.90273,"avg":-11.967809,"sd":3.368935,"marketCap":607743960},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293},{"date":"2025-06-13","current":-11.90781,"twenty":-15.527784,"median":-10.843036,"eighty":-8.663027,"marketCap":845013916},{"date":"2025-06-20","current":-10.863051,"twenty":-15.401128,"median":-10.973025,"eighty":-8.671464,"marketCap":770874676},{"date":"2025-06-27","current":-9.158444,"twenty":-15.033515,"median":-10.853044,"eighty":-8.690985,"marketCap":649910652},{"date":"2025-07-03","current":-8.260318,"twenty":-14.588672,"median":-10.413035,"eighty":-8.668829,"marketCap":586176919},{"date":"2025-07-11","current":-8.284756,"twenty":-14.14074,"median":-9.690076,"eighty":-8.535817,"marketCap":587911170},{"date":"2025-07-18","current":-8.043423,"twenty":-13.87507,"median":-9.628891,"eighty":-8.433029,"marketCap":570785439},{"date":"2025-07-25","current":-8.816301,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"marketCap":625631134},{"date":"2025-08-01","current":-10.285126,"twenty":-12.797445,"median":-9.491423,"eighty":-8.48456,"marketCap":729863398},{"date":"2025-08-08","current":-9.243749,"twenty":-12.637058,"median":-9.506697,"eighty":-8.519369,"marketCap":655964186},{"date":"2025-08-15","current":-10.23612,"twenty":-12.367549,"median":-9.430326,"eighty":-8.524348,"marketCap":726385788},{"date":"2025-08-22","current":-10.346383,"twenty":-12.210773,"median":-9.506697,"eighty":-8.53478,"marketCap":734210411},{"date":"2025-08-29","current":-11.461269,"twenty":-12.163662,"median":-9.628891,"eighty":-8.548511,"marketCap":813326038},{"date":"2025-09-05","current":-12.312748,"twenty":-12.179108,"median":-9.681286,"eighty":-8.567484,"marketCap":873749512},{"date":"2025-09-12","current":-15.522638,"twenty":-12.446687,"median":-9.727683,"eighty":-8.641901,"marketCap":1101532967},{"date":"2025-09-19","current":-13.656808,"twenty":-13.735035,"median":-10.052347,"eighty":-8.661432,"marketCap":1001986381},{"date":"2025-09-26","current":-13.111721,"twenty":-13.639034,"median":-10.266749,"eighty":-8.666193,"marketCap":961993866},{"date":"2025-10-03","current":-12.140044,"twenty":-13.564381,"median":-10.319662,"eighty":-8.681485,"marketCap":890702861},{"date":"2025-10-10","current":-13.17097,"twenty":-13.533571,"median":-10.444395,"eighty":-8.70255,"marketCap":966340878},{"date":"2025-10-17","current":-12.222992,"twenty":-13.435219,"median":-10.631231,"eighty":-8.716023,"marketCap":896788678},{"date":"2025-10-24","current":-11.858613,"twenty":-13.293022,"median":-10.863051,"eighty":-8.739096,"marketCap":870054551},{"date":"2025-10-31","current":-15.145803,"twenty":-13.564381,"median":-11.055506,"eighty":-8.749568,"marketCap":1178979618},{"date":"2025-11-07","current":-14.161722,"twenty":-13.91523,"median":-11.228491,"eighty":-8.756685,"marketCap":1102376760},{"date":"2025-11-14","current":-14.840399,"twenty":-14.167423,"median":-11.440151,"eighty":-8.762559,"marketCap":1155206317},{"date":"2025-11-21","current":-16.062017,"twenty":-14.833302,"median":-11.540904,"eighty":-8.774755,"marketCap":1250299520},{"date":"2025-11-28","current":-17.724775,"twenty":-15.145803,"median":-11.576718,"eighty":-8.779642,"marketCap":1379731935},{"date":"2025-12-05","current":-16.966919,"twenty":-15.332439,"median":-11.635852,"eighty":-8.816301,"marketCap":1320738930},{"date":"2025-12-12","current":-16.57668,"twenty":-15.394651,"median":-11.66167,"eighty":-8.816301,"marketCap":1290361934},{"date":"2025-12-19","current":-16.435289,"twenty":-15.547354,"median":-11.719728,"eighty":-8.816301,"marketCap":1279355776},{"date":"2025-12-26","current":-17.583384,"twenty":-15.759893,"median":-11.773049,"eighty":-8.818649,"marketCap":1368725777},{"date":"2026-01-02","current":-17.232734,"twenty":-15.960216,"median":-11.858773,"eighty":-8.819236,"marketCap":1341430506},{"date":"2026-01-09","current":-18.092392,"twenty":-16.141928,"median":-11.883371,"eighty":-8.865131,"marketCap":1408347945},{"date":"2026-01-16","current":-10.061383,"twenty":-16.097911,"median":-11.858773,"eighty":-8.897333,"marketCap":783198185},{"date":"2026-01-23","current":-9.334633,"twenty":-16.07559,"median":-11.773049,"eighty":-8.931179,"marketCap":726626534},{"date":"2026-01-30","current":-8.364691,"twenty":-16.041657,"median":-11.675641,"eighty":-8.819236,"marketCap":651124292},{"date":"2026-02-06","current":-7.488067,"twenty":-15.977182,"median":-11.659491,"eighty":-8.794306,"marketCap":582886114},{"date":"2026-02-13","current":-7.663392,"twenty":-15.919488,"median":-11.620538,"eighty":-8.751152,"marketCap":596533750},{"date":"2026-02-20","current":-8.157068,"twenty":-15.904664,"median":-11.576718,"eighty":-8.716023,"marketCap":597097350},{"date":"2026-02-23","current":-8.302513,"twenty":-15.900031,"median":-11.573987,"eighty":-8.704615,"marketCap":607743960}],"updateTime":1771973776286},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614729070","title":"BRIEF-Beta Bionics Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729070","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729070?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:05","pubTimestamp":1771974341,"startTime":"0","endTime":"0","summary":"BRIEF-Beta Bionics Inc Files For Mixed Shelf Size Not Disclosed - SEC FilingFeb 24  - Beta Bionics Inc BBNX.O:BETA BIONICS INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001193125-26-067433]Further company coverage: BBNX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2614472951","title":"Faruqi & Faruqi Probes Beta Bionics for Potential Investor Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2614472951","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614472951?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:41","pubTimestamp":1771972861,"startTime":"0","endTime":"0","summary":"Faruqi and Faruqi is investigating potential investor claims against Beta Bionics Inc., alleging the company may have issued misleading statements or failed to disclose information important to investors. The probe follows a sharp drop in Beta Bionics shares after the company said it expects fewer fourth-quarter patient starts than analysts had estimated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL5mNSgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2612283977","title":"Faruqi & Faruqi Probes Investor Claims Against Beta Bionics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2612283977","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612283977?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:21","pubTimestamp":1771510885,"startTime":"0","endTime":"0","summary":"Faruqi & Faruqi, LLP said it is investigating potential securities claims on behalf of investors in Beta Bionics Inc., focusing on whether the company made misleading statements or failed to disclose material information. The firm pointed to a sharp share-price drop after Beta Bionics said it expected fewer fourth-quarter patient starts than analysts had estimated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL5xXjQK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4112","SG9999014039.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4588","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4585","LU0314104364.USD","SG9999014021.USD","BK4082","BBNX","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ"],"gpt_icon":0},{"id":"2612475010","title":"Beta Bionics (BBNX) Revenue Growth Outpaces Persistent Losses And Tests Bullish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2612475010","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612475010?lang=en_us&edition=fundamental","pubTime":"2026-02-19 09:28","pubTimestamp":1771464485,"startTime":"0","endTime":"0","summary":"Beta Bionics (BBNX) just closed out FY 2025 with Q4 revenue of US$32.1 million and a net loss of US$13.5 million, which translated to EPS of US$0.30 loss, while trailing 12 month revenue reached US$100.3 million alongside a net loss of US$73.2 million and EPS of US$1.81 loss. Over recent quarters the company has seen revenue move from US$17.6 million and EPS of US$0.93 loss in Q1 2025 to US$27.3 million and EPS of US$0.33 loss in Q3 2025, before landing at the latest Q4 run rate. For...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-bbnx/beta-bionics/news/beta-bionics-bbnx-revenue-growth-outpaces-persistent-losses","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-bbnx/beta-bionics/news/beta-bionics-bbnx-revenue-growth-outpaces-persistent-losses","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","BBNX","BLSG","BK4112","BLSX"],"gpt_icon":0},{"id":"2612445090","title":"Beta Bionics Is Maintained at Neutral by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445090?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:14","pubTimestamp":1771420440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2026 08:14 ET (13:14 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2612244838","title":"Beta Bionics price target lowered to $22 from $25 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2612244838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612244838?lang=en_us&edition=fundamental","pubTime":"2026-02-18 19:51","pubTimestamp":1771415477,"startTime":"0","endTime":"0","summary":"Stifel analyst Jonathan Block lowered the firm’s price target on Beta Bionics (BBNX) to $22 from $25 and keeps a Buy rating on the shares. Q4 resul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-22-from-25-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-22-from-25-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","SF"],"gpt_icon":0},{"id":"2612419101","title":"Beta Bionics Inc : Leerink Partners Cuts Target Price to $25 From $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2612419101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612419101?lang=en_us&edition=fundamental","pubTime":"2026-02-18 16:18","pubTimestamp":1771402683,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZD1AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2612903354","title":"Hold Rating Maintained as In-Line Results and Improving Margins Offset Near-Term Prescription Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2612903354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612903354?lang=en_us&edition=fundamental","pubTime":"2026-02-18 11:35","pubTimestamp":1771385733,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Mathew Blackman from TD Cowen maintained a Hold rating on Beta Bionics, Inc., with a price target of $16.00. Mathew...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hold-rating-maintained-as-in-line-results-and-improving-margins-offset-near-term-prescription-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hold-rating-maintained-as-in-line-results-and-improving-margins-offset-near-term-prescription-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2612495352","title":"Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M","url":"https://stock-news.laohu8.com/highlight/detail?id=2612495352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612495352?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:55","pubTimestamp":1771365325,"startTime":"0","endTime":"0","summary":"Estimated 36% to 38% of new patient starts reimbursed through the PBP channel. Estimated gross margin of 55.5% to 57.5% Published first on TheFly –...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-sees-fy26-revenue-130m-135m-consensus-132-68m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-sees-fy26-revenue-130m-135m-consensus-132-68m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2612331495","title":"Beta Bionics reports Q4 EPS (30c), consensus (38c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612331495","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612331495?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:50","pubTimestamp":1771365027,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $32.12M, consensus $31.07M. “Beta Bionics (BBNX) exists to deliver solutions to people with diabetes that reduce burden, expand ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-reports-q4-eps-30c-consensus-38c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-reports-q4-eps-30c-consensus-38c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2612460709","title":"Beta Bionics Q4 sales rise 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460709?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:16","pubTimestamp":1771363003,"startTime":"0","endTime":"0","summary":"Beta Bionics Q4 sales rise 57%OverviewDiabetes management firm's Q4 net sales rose 57% yr/yrAdjusted EBITDA for Q4 beat analyst expectationsOutlookBeta Bionics estimates 2026 revenue between $130 mln ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nL1N3ZD0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2612946055","title":"BRIEF-Beta Bionics Inc Q4 EPS USD -0.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2612946055","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612946055?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362347,"startTime":"0","endTime":"0","summary":"Feb 17  - Beta Bionics Inc Q4 gross profit USD 18.944 million.Q4 adjusted EBITDA USD -10.512 million vs. IBES estimate USD -14.8 million. Q4 income from operations USD -16.124 million vs. IBES estimate USD -20.5 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nPLX5993A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2612460545","title":"Beta Bionics Inc. FY 2025 net loss USD 73.2 million, down 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460545","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460545?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362332,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc. reported full year  2025 net sales of USD 100.25 million, with a gross profit of USD 55.54 million and a gross margin of 55.4%. The company posted a net loss of USD 73.2 million, representing negative 73% of sales, an improvement compared to negative 84% of sales in the previous year. Loss from operations was USD 71.7 million, or negative 72% of sales. Adjusted EBITDA for the period was negative USD 52.8 million, or negative 53% of sales. Beta Bionics continues as a commercial-stage medical device company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL3jW9gg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","BK4082","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","NDAQ","LU0314104364.USD","SG9999014039.USD","BK4588","IE00B3QW5Z07.USD","BBNX","SG9999014005.SGD","BK4585","LU2210150020.SGD","BK4112"],"gpt_icon":0},{"id":"2612608504","title":"Beta Bionics Inc Q4 Gross Profit USD 18.944 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612608504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612608504?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nPLX5993A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2612460914","title":"Press Release: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460914?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 17, 2026  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2025 and introduced its annual guidance for the year ending December 31, 2026.Fourth Quarter 2025 Financial Highlights & Key Metrics. -- Net sales of $32.1 million, up 57% compared to $20.4 million in the. -- Durable Medical Equipment  channel net sales of $22.3 million,up 24% compared to $18.0 million in the fourth quarter of 2024.-- Pharmacy Benefit Plan  channel net sales of $9.8 million, up. 295% compared to $2.5 million in the fourth quarter of 2024.-- Gross margin of 59.0%, up 179 basis points compared to 57.2% in the. -- Installed customer base (calculated as all new patient starts over a. rolling four-year period) of 35,011 users, up 129% compared to 15,298 in. -- 5,592 new patient starts, up 37% compared to 4,084 new patient starts in. -- 69% of new patient start","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBP","BK4082","BBNX"],"gpt_icon":0},{"id":"2612456855","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2612456855","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612456855?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:00","pubTimestamp":1771326000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Element Sol. Inc                                  4Q       .36   4:15 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENLT","CE","BLCO","ADI","BKD","ATRC","CLW","DVN","BELFB","CVNA","CSR","ADAM","AGI","BNL","CF","AWK","ET","BKNG","ANDE","CDE","CMTG","AMRZ","BORR","BLDR","ESI","CAKE","CAR","BELFA","BRSP","CRNT","AMPL","ARR","CZR","CDNS","ECC","CNK","CRL","ACCO","CWAN","DFIN","CLH","CAMT","DTE","EQT","CEVA","BHC","BBNX","ALLE","CNH","ACLS"],"gpt_icon":0},{"id":"2611155620","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2611155620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611155620?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:00","pubTimestamp":1770980400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Adv. Auto Parts                                  4Q       .41   6:30 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLE","BLDR","CE","FLR","ADI","CEVA","CRSP","FE","AGI","DVN","AMPL","BBNX","CCJ","EQT","ACLS","ET","CAR","DFIN","CDNS","FELE","DTE","ADAM","EXE","ESI","ATRC","AWK","SMWB","BRSP","BNTC","AERO","ENB","ESNT","BHC","ARR","AAP","CZR","ETOR","CIGI","DCH","CNH","CRNT","ATMU","BELFA","CSR","ACCO","ANDE","BLCO","BELFB","AMRZ","ENLT"],"gpt_icon":0},{"id":"2610372946","title":"UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610372946","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610372946?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:14","pubTimestamp":1770639291,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) has an average rating of overweight and mean price target of $28.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2610531508","title":"Beta Bionics initiated with a Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2610531508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610531508?lang=en_us&edition=fundamental","pubTime":"2026-02-09 05:15","pubTimestamp":1770585305,"startTime":"0","endTime":"0","summary":"UBS initiated coverage of Beta Bionics (BBNX) with a Buy rating and $24 price target Published first on TheFly – the ultimate source for real-time,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU3187612489.SGD","IE0034235071.USD","LU1863844749.USD","BK4534","UBS","BK4588","BK4082","BBNX","BK4118","LU1863844665.USD","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"2608362578","title":"Beta Bionics Is Maintained at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362578","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608362578?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:27","pubTimestamp":1770211620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 08:27 ET (13:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","SF"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}]}}